[Increased phospholipase A2 and diacylglycerol lipase activities in colorectal carcinoma: possibility for carcinoma prevention or therapy?].
Sadowski
C
C
Klinik für Viszerale und Transplantationschirurgie, Universitätsspital Bern.
Uhl
W
W
D000368:Aged; D000369:Aged, 80 and over; D003106:Colon / Q000187:drug effects / Q000473:pathology; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism*; D054467:Phospholipases A2; D012007:Rectum / Q000187:drug effects / Q000473:pathology
D004791:Enzyme Inhibitors; D010741:Phospholipases A; D008071:Lipoprotein Lipase; D054467:Phospholipases A2
Erhöhte Phospholipase A2 und Diacylglycerollipase-Aktivitäten bei kolorektalem Karzinom: Angriffspunkt zur Karzinomverhinderung oder Therapie?